Related Experiment Videos

Portosystemic shunts for extrahepatic portal hypertension in children

Surgery, Gynecology & Obstetrics
|July 1, 1981
PubMed

Insights

Portosystemic shunts effectively treat children with prehepatic portal hypertension and bleeding varices. Mesocaval shunts are favored for their patency and spleen preservation, preventing re-bleeding in most pediatric patients.

Area of Science:

  • Pediatric Surgery
  • Hepatology
  • Vascular Surgery

Background:

  • Prehepatic portal hypertension in children often leads to severe hemorrhage from esophagogastric varices.
  • Ruptured varices pose a significant risk of mortality and morbidity in pediatric patients.
  • Portal vein anomalies, such as cavernomatosis and double portal veins, are common in this population.

Purpose of the Study:

  • To evaluate the efficacy and safety of portosystemic shunts in managing pediatric prehepatic portal hypertension with variceal hemorrhage.
  • To compare outcomes between different types of portosystemic shunts in children.
  • To determine the long-term patency and complication rates of these shunts.

Main Methods:

  • A cohort of 23 children with prehepatic portal hypertension and variceal bleeding underwent portosystemic shunt surgery.
  • The study included patients aged 2.7 to 15 years, with 11 under eight years old.
  • Procedures included 21 mesocaval shunts and 2 splenorenal shunts; patient data were analyzed for outcomes.

Main Results:

  • No surgical mortality was observed.
  • Two shunts occluded in very young infants (2.7 and 3 years old).
  • The remaining shunts remained patent, with no further bleeding episodes in 21 patients; only one patient developed neuropsychiatric disorders.

Conclusions:

  • Elective portosystemic shunt surgery is recommended for children experiencing major variceal hemorrhage due to prehepatic portal hypertension.
  • The mesocaval shunt is favored due to larger vessel anastomosis and spleen preservation, crucial for infection defense.
  • Portosystemic shunting demonstrates a favorable risk-benefit profile for preventing recurrent variceal bleeding in pediatric patients.

Related Concept Videos